Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Danielle Potter"'
Publikováno v:
JCO Oncology Practice. 18:e1265-e1277
PURPOSE: Understanding risks for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and subsequent mortality among patients with cancer may help inform treatment decisions during the COVID-19 pandemic. METHODS: CancerLinQ is an el
Publikováno v:
Drugs - Real World Outcomes. 9:333-345
Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are standard-of-care first-line (1L) treatment for EGFR mutation-positive advanced/metastatic non-small cell lung cancer. In 2015, osimertinib, a third-generation EGFR-TKI, recei
Autor:
Suanna S. Bruinooge, Ash B. Alpert, Becky Koronkowski, Danielle Potter, Don S. Dizon, George Anthony Komatsoulis, Robert S. Miller, Elizabeth Garrett-Mayer, Edward J. Stepanski, Stephen C. Meersman
Publikováno v:
JCO Oncology Practice. 17:e336-e342
PURPOSE: Cancer prevalence and outcomes data, necessary to understand disparities in transgender populations, are significantly hampered because gender identity data are not routinely collected. A database of clinical data on people with cancer, Canc
Autor:
Shaum M Kabadi, Danielle Potter, Aliki Taylor, Mark F Riffon, Brittany Manning, Robert S. Miller, Cathy Emmas, Miao Jiang
Publikováno v:
JCO clinical cancer informatics. 5
PURPOSE In 2014, the ASCO developed CancerLinQ (CLQ), a health technology platform for oncology. The CLQ Discovery (CLQD) database was created to make data available for research and this paper provides a summary of this database. METHODS This study
Autor:
Elisa Baelen, Sonia Rojas-Farreras, Sudeep Karve, Jesús Rodríguez-Baño, Pascale Peeters, Danielle Potter, Kellie Ryan
Publikováno v:
Infection and Drug Resistance
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Pascale Peeters,1 Kellie Ryan,2 Sudeep Karve,2 Danielle Potter,3 Elisa Baelen,4 Sonia Rojas-Farreras,5 Jesús Rodríguez-Baño6 1Real-World Insights, IQVIA, Saint-Ouen, France; 2Health Economics and Outcomes Research, AstraZeneca, Gaithersburg, MD, U
Autor:
Danielle Potter, Raven Brothers, Andrej Kolacevski, Jacob E. Koskimaki, Amy McNutt, Robert S. Miller, Jatin Nagda, Anil Nair, Wendy S. Rubinstein, Andrew K. Stewart, Iris J. Trieb, George A. Komatsoulis
Publikováno v:
JCO Clin Cancer Inform
PURPOSE ASCO, through its wholly owned subsidiary, CancerLinQ LLC, developed CancerLinQ, a learning health system for oncology. A learning health system is important for oncology patients because less than 5% of patients with cancer enroll in clinica
Autor:
Naveen Kumar, Norah J. Shire, Robert Brody, Danielle Potter, Danielle Greenawalt, Jill Walker, Matthew B. Schabath, Shane Huntsman, Hongyue A Dai, Tapashi Dalvi, Alan Crim, Jhanelle E. Gray, Nicholas T. Gimbrone, J. Rigas, David Lawrence, Anita Midha
Publikováno v:
Cancer Management and Research
Matthew B Schabath,1,2 Tapashi B Dalvi,3 Hongyue A Dai,4 Alan L Crim,4 Anita Midha,5 Norah Shire,3 Nicholas T Gimbrone,1 Jill Walker,6 Danielle M Greenawalt,7 David Lawrence,8 James R Rigas,9 Robert Brody,9 Danielle Potter,9 Naveen S Kumar,4 Shane A
Autor:
Sonia Rojas-Farreras, Kellie Ryan, Esther Pascual, Pascale Peeters, Danielle Potter, Elisa Baelen, Sudeep Karve, Jesús Rodríguez-Baño
Publikováno v:
Journal of Infection. 77:9-17
Summary Objectives To assess real-world treatment patterns and clinical outcomes associated with initial antibiotic therapy (IAT, antibiotics received ≤ 48 h post-initiation of antibiotic therapy), including level of IAT failure, and potential risk
Autor:
Electra D. Paskett, Gabrielle B. Rocque, Mark Riffon, Jennifer C. King, Danielle Potter, Abdul Rahman Jazieh
Publikováno v:
Journal of Clinical Oncology. 39:310-310
310 Background: For patients with cancer approaching end-of-life (EOL) during the COVID-19 pandemic, the changes in service availability and transition to telehealth may impact care delivery. Little is known about how the COVID-19 pandemic impacted E
Autor:
Danielle Potter, J. King, Mark Riffon, Abdul Rahman Jazieh, Gabrielle B. Rocque, Electra D. Paskett
Publikováno v:
Journal of Clinical Oncology. 39:6547-6547
6547 Background: The COVID-19 pandemic disrupted all facets of healthcare delivery including cancer care. This study evaluates the disruptions to US medical oncology practice during the pandemic in terms of number and type of patients (pts) encounter